Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.
Saved in:
| Title: | Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply. |
|---|---|
| Authors: | Colhoun HM; Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK; Public Health Scotland, Glasgow, UK. Electronic address: helen.colhoun@igmm.ed.ac.uk., McGurnaghan SJ; Institute of Genetics and Molecular Medicine, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK; Public Health Scotland, Glasgow, UK., McKeigue PM; Public Health Scotland, Glasgow, UK; Usher Institute College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK. |
| Source: | The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2021 Apr; Vol. 9 (4), pp. 201. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2213-8595 |
|---|---|
| DOI: | 10.1016/S2213-8587(21)00055-3 |
